BIOGENERA

biogenera-logo

BIOGENERA SpA is a company operating in the biotechnology pharmaceutical sector, specialising in the research and development of new DNA-based patient-specific biotechnological medicines for the treatment of serious pathologies. BIOGENERA SpA is an Innovative Small and Medium-sized Enterprise (ISME) with a multidisciplinary team of researchers and is supported by numerous University partnerships (in particular, the University of Bologna) and other companies of the pharmaceutical sector.

#People #Financial #Website #More

BIOGENERA

Industry:
Biopharma Biotechnology Health Care Pharmaceutical

Founded:
2008-01-01

Address:
Bologna, Emilia-Romagna, Italy

Country:
Italy

Website Url:
http://www.biogenera.com

Total Employee:
11+

Status:
Active

Contact:
+39 051 05 63 250

Email Addresses:
[email protected]

Total Funding:
5.38 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon WordPress Google Universal Analytics Font Awesome Wordpress Plugins


Current Employees Featured

not_available_image

Kaivon Talai
Kaivon Talai Business Operations and Development @ Biogenera
Business Operations and Development

andrea-pession_image

Andrea Pession
Andrea Pession Co-Founder @ Biogenera
Co-Founder

valentina-bertuccioli_image

Valentina Bertuccioli
Valentina Bertuccioli CEO & Board Member @ Biogenera
CEO & Board Member
2009-01-01

Founder


andrea-pession_image

Andrea Pession

roberto-tonelli_image

Roberto Tonelli

Investors List

embed-capital_image

Embed Capital

Embed Capital investment in Seed Round - Biogenera

ingenium-emilia-romagna_image

INGENIUM Emilia Romagna

INGENIUM Emilia Romagna investment in Seed Round - Biogenera

Official Site Inspections

http://www.biogenera.com

  • Host name: mxd5.aruba.it
  • IP address: 62.149.128.74
  • Location: Arezzo Italy
  • Latitude: 43.4631
  • Longitude: 11.8783
  • Timezone: Europe/Rome
  • Postal: 52100

Loading ...

More informations about "Biogenera"

Who we are โ€“ BIOGENERA SpA

BIOGENERA SpA is a company operating in the biotechnology pharmaceutical sector, specialising in the research and development of new DNA-based patient-specific โ€ฆSee details»

Biogenera - Crunchbase Company Profile & Funding

BIOGENERA SpA is a company operating in the biotechnology pharmaceutical sector, specialising in the research and development of new DNA-based patient-specific โ€ฆSee details»

BIOGENERA SpA

BIOGENERA SpA - Copyright 2024See details»

BIOGENERA SpA - LinkedIn

BIOGENERA SpA is a company operating in the biotechnology pharmaceutical sector, specialising in the research and development of new DNA-based patient-specific โ€ฆSee details»

Biogenera Company Profile 2024: Valuation, Funding & Investors

Biogenera General Information Description. Developer of therapeutic drugs designed to provide treatment for pediatric cancer. The company's platform MyGenera can quickly identify and โ€ฆSee details»

Biogenera - VentureRadar

" BIOGENERA SpA is a company operating in the biotechnology pharmaceutical sector, specialising in the research and development of new DNA-based patient-specific โ€ฆSee details»

Biogenera Company Profile - Office Locations, Competitors ... - Craft

Biogenera is a company operating in the biotechnology pharmaceutical sector and focusing on the research and development of DNA-based medicines. It offers MyGeneraTM platform that โ€ฆSee details»

Biogenera - Crunchbase Company Profile & Funding

Organization. Biogenera . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. Biogenera is a biotechnology company that operates in the โ€ฆSee details»

Biogenera - Crunchbase

BIOGENERA SpA is a company operating in the biotechnology pharmaceutical sector.See details»

Biogenera - Products, Competitors, Financials, Employees, โ€ฆ

Biogenera provides a range of research and development services for DNA-based biotechnological medicines for serious pathologies. It specializes in creating patient-specific โ€ฆSee details»

What we do โ€“ BIOGENERA SpA

For BIOGENERA SpA, DNA, the distinctive element that makes each person unique, is the true target of gene-specific therapy. While traditional pharmacological approaches act on โ€ฆSee details»

Biogenera - Company Profile - Tracxn

Nov 5, 2024 Biogenera - Developer of therapeutics for the treatment of cancer in pediatric patients. Raised a total funding of $1.36M over 3 rounds from 8 investors. Founded by Andrea โ€ฆSee details»

BIOGENERA - Overview, News & Similar companies | ZoomInfo.com

BIOGENERA contact info: Phone number: +39 510563250 Website: www.biogenera.com What does BIOGENERA do? Founded in 2018 and headquartered in Ozzano dell'Emilia, Italy, โ€ฆSee details»

Biogenera - Funding, Financials, Valuation & Investors - Crunchbase

How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial โ€ฆSee details»

BIOGENERA - F6S

BIOGENERA SpA is a company that operates in the pharmaceutical biotechnology sector, specializing in the research and development of new DNA-based biotechnological drugs for โ€ฆSee details»

Biogenera, la società nata a Bologna che vuole curare il cancro ...

Sep 2, 2022 Roberto Tonelli โ€“ ricercatore di Farmacologia e Biotecnologia presso lโ€™Università di Bologna. Assieme hanno fondato Biogenera Spa, che oggi è diventata una realtà che โ€ฆSee details»

News โ€“ BIOGENERA SpA

BIOGENERA SpA will attend the Bio Europe Spring international congress to be held in Barcelona on March 18, 19 and 20, 2024. Building on the success of EBD Groupโ€™s flagship โ€ฆSee details»

Biogenera - Contacts, Employees, Board Members, Advisors

Biogenera has 3 current employee profiles, including Business Operations and Development Kaivon Talai. Kaivon Talai Business Operations and Development Andrea Pession Co-FounderSee details»

Partners โ€“ BIOGENERA SpA

BIOGENERA SpA has decided to take-up this important challenge, however complex it may be: to embark on a new era in personalised DNA based medicines, that are really โ€œmade to โ€ฆSee details»

PIPELINE โ€“ BIOGENERA SpA

BIOGENERA SpA has concluded its pre-clinical studies of BGA002, the first and only international level medicine that acts directly and specifically in blocking the tumoral gene MYCN, for the โ€ฆSee details»

linkstock.net © 2022. All rights reserved